1. WY-50,324;Abou-Gharbia;Drugs Future,1990
2. WY-47,846;Abou-Gharbia;Drugs Future,1989
3. Open trial of gepirone in the treatment of major depressive disorder;Amsterdam;Curr. Ther. Res.,1987
4. Preclinical neuropharmacological profile of WY-48,723, a potent serotonin (5-HT1A) agonist;Andree;Soc. Neurosci. Abstr.,1988
5. Anticonflict and discriminative stimulus effects of the 5-HT1A compounds WY-47,846 and WY-48,723 and the mixed 5-HT1A agonist/5-HT2 antagonist WY-50,324 in pigeons;Barrett;Drug Dev. Res.,1991